Clinical Trial Update: Study Comparing Estradiol Vaginal Inserts 4mcg To IMVEXXY ® (Estradiol Vaginal Inerts 4 mcg) In The Treatment Of Dyspareunia in Women With Vulvur and Vaginal Atrophy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing Estradiol Vaginal Inserts 4 mcg to IMVEXXY for the treatment of dyspareunia in women with vulvar and vaginal atrophy has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspareunia
• Vulvar and Vaginal Atrophy

Drugs mentioned

• Estradiol Vaginal Inserts 4 mcg (estradiol vaginal inserts)
• IMVEXXY (Estradiol)

Snippet

Sponsor: Teva Pharmaceuticals USA | Conditions: Dyspareunia | Phase 3 | Status: COMPLETED